MGB Glomerular Disease Conference 2027

This is a live activity.

The 2-Day Glomerular Disease Conference will bring together clinicians and researchers to discuss recent advances in the understanding and management of glomerular diseases. The program will highlight emerging therapeutic strategies, clinical trial updates, and practical considerations for incorporating new agents into patient care. Sessions will include expert lectures, interactive case discussions, and debates. The conference aims to provide attendees with up-to-date, actionable insights that bridge science and clinical practice.

Target audience

This activity is intended for nephrologists taking care of patients with autoimmune and rare kidney disease.

Learning objectives

Upon completion of this activity, participants will be able to:

1. Review and interpret recent evidence-based clinical trials in glomerular diseases and their impact on treatment strategies.

2. Apply current data to the use of novel immunologic and complement-targeted therapies in clinical practice.

3. Integrate personalized approaches and nuanced decision-making to optimize patient outcomes in glomerular disease management.

Registration instructions

Cancellation Policy:
Registrations cancelled on or before May 16, 2026 will be refunded, less a $15 administrative fee. Registrations cancelled after May 16, 2026 will not be refunded.

Contact Maxine Harney if you require assistance in cancelling your online registration.

Additional information

Faculty credentials

Conference Co-Directors

Harish Seethapathy, MD
Assistant Professor of Medicine, Harvard Medical School
Associate Physician, Massachusetts General Hospital

Ayman Al Jurdi, MD
Assistant Professor of Medicine, Harvard Medical School
Assistant in Medicine, Massachusetts General Hospital

Faculty

TBA

Accreditation

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 Credits^TM
Mass General Brigham designates this live activity for a maximum of 8.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC RECOGNITION STATEMENT

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Program